葡萄膜炎中的角膜内皮移植:发生率与危险因素
基于美国三级葡萄膜炎诊疗机构非感染性眼部炎症患者的回顾性队列研究,14,264只眼纳入分析,中位随访1.8眼年,10年内角膜内皮移植的Kaplan-Meier估计发生率为1.10%(95%CI,0.68%-1.53%)。年龄>60岁、前葡萄膜炎和巩膜炎、局部皮质类固醇治疗、白内障手术、引流管植入手术、带状角膜病变和低眼压与角膜内皮移植风险升高相关。
要点
- 非感染性眼部炎症患者10年内角膜内皮移植的Kaplan-Meier估计发生率为1.10%(95%CI,0.68%-1.53%)。
- 引流管植入手术(aHR,11.9)、低眼压(aHR,7.38)、带状角膜病变(aHR,5.12)与角膜内皮移植风险升高相关。
- 年龄>60岁较<40岁、前葡萄膜炎、巩膜炎、局部皮质类固醇治疗和白内障手术亦与风险升高相关。
核心结论
- 在眼部炎症患者中,角膜内皮移植不常发生。
- 引流管植入手术、低眼压、带状角膜病变、白内障手术和前节炎症与接受角膜内皮移植的风险升高相关;这些因素可能与内皮细胞损伤有关。
研究设计与样本
- 回顾性队列研究,纳入美国三级葡萄膜炎诊疗机构中诊断为非感染性眼部炎症的成人患者,数据来自 Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study。
- 共14,264只眼符合分析标准,中位随访1.8眼年,采用时间-事件分析估计角膜内皮移植发生率,并用Cox回归评估潜在危险因素,同时考虑同一患者双眼间的相关性。
主要发现
- 10年内角膜内皮移植的Kaplan-Meier估计发生率为1.10%(95%CI,0.68%-1.53%)。
- 年龄>60岁 vs <40岁的校正风险比(aHR)为16.5(95%CI,4.70-57.9)。
- 前葡萄膜炎 vs 其他类型的aHR为2.97(95%CI,1.46-6.05),巩膜炎 vs 其他类型的aHR为4.14(95%CI,1.28-13.4)。
- 局部皮质类固醇治疗的aHR为2.84(95%CI,1.32-6.13),白内障手术的aHR为4.44(95%CI,1.73-11.4)。
- 引流管植入手术的aHR为11.9(95%CI,5.30-26.8),带状角膜病变的aHR为5.12(95%CI,2.34-11.2),低眼压的aHR为7.38(95%CI,3.14-17.4)。
关键数值与推荐
- 葡萄膜炎病程、小梁切除术、周边虹膜前粘连和高眼压在多因素校正后无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To estimate the incidence of corneal endothelial transplantation (CET) and identify risk factors among patients with noninfectious ocular inflammation. DESIGN: Retrospective cohort study. METHODS: Adult patients attending United States tertiary uveitis care facilities diagnosed with noninfectious ocular inflammation were identified from the Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Time-to-event analysis was used to estimate the incidence of CET, including penetrating keratoplasty, Descemet stripping endothelial keratoplasty, or Descemet membrane endothelial keratoplasty procedures. The incidence of CET was calculated. Potential risk factors for CET were also evaluated using Cox regression, accounting for correlation between eyes of the same patient. RESULTS: Overall, 14,264 eyes met eligibility criteria for this analysis, with a median follow-up of 1.8 eye-years. The Kaplan-Meier estimated incidence of CET within 10 years was 1.10% (95% CI, 0.68%-1.53%). Risk factors for CET included age >60 years vs <40 years (adjusted hazard ratio [aHR], 16.5; 95% CI, 4.70-57.9), anterior uveitis and scleritis vs other types (aHR, 2.97; 95% CI, 1.46-6.05; and aHR, 4.14; 95% CI,1.28-13.4, respectively), topical corticosteroid treatment (aHR, 2.84; 95% CI, 1.32-6.13), cataract surgery (aHR, 4.44; 95% CI, 1.73-11.4), tube shunt surgery (aHR, 11.9; 95% CI, 5.30-26.8), band keratopathy (aHR, 5.12; 95% CI, 2.34-11.2), and hypotony (aHR, 7.38; 95% CI, 3.14-17.4). Duration of uveitis, trabeculectomy, peripheral anterior synechia, and ocular hypertension had no significant association after multivariate adjustment. CONCLUSIONS: In patients with ocular inflammation, CET occurred infrequently. Tube shunt surgery, hypotony, band keratopathy, cataract surgery, and anterior segment inflammation were associated with increased risk of undergoing CET; these factors likely are associated with endothelial cell damage.
引用
- Roldan AM, Zebardast N, Pistilli M, et al. Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors. Am J Ophthalmol. 2021. PMID: 34780793. doi:10.1016/j.ajo.2021.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。